MIT researchers have developed an artificial intelligence tool that listens to a person's coughing to determine whether or not they may have COVID-19, regardless if they are or are not symptomatic, according to research published last week in IEEE Open Journal of Engineering.
To build it, the researchers solicited audio recordings of individuals coughing and accompanying information about their...
Yesterday PathAI, a Boston-based maker of artificial intelligence tools for pathology, closed a $60 million Series B funding round led by General Atlantic. Other existing investors, most notably General Catalyst, also participated in the round.
To monitor its investment, General Atlantic Managing Director Dr. Michelle Dipp will also be joining the AI company’s board of directors.
WHAT THEY DO...
Out of the 422 million people around the world living with diabetes, one in three of them will develop diabetic retinopathy (DR), a common condition that can lead to permanent blindness if left untreated. While early detection and treatment can dramatically reduce that risk, a third of people with diabetes have never even been screened for DR, as many are living in low-income, medically...
